| 601 |
abnormal |
post-translational protein modification
(GO:0043687)
|
osteocalcin
(PR:000030444)
|
1169: Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin
|
| 602 |
decreased |
carboxylation reaction
(MI:1139)
|
matrix Gla protein (mouse)
(PR:P19788)
|
1169: Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin
|
| 603 |
decreased |
catalytic activity
(GO:0003824)
|
iodotyrosine deiodinase 1 (human)
(PR:Q6PHW0)
|
1152: Inhibition, Iodotyrosine deiodinase (IYD)
|
| 604 |
decreased |
catalytic activity
(GO:0003824)
|
type III iodothyronine deiodinase
(PR:000006482)
|
1153: Inhibition, Deiodinase 3
|
| 605 |
decreased |
signaling
(GO:0023052)
|
pendrin
(PR:000015039)
|
1155: Inhibition, Pendrin
|
| 606 |
decreased |
catalytic activity
(GO:0003824)
|
dual oxidase 1
(PR:000006727)
|
1156: Inhibition, Dual oxidase
|
| 607 |
increased |
signaling
(GO:0023052)
|
protein
(PR:000000001)
|
1157: Activation, Hepatic nuclear receptor(s)
|
| 608 |
increased |
transport
(GO:0006810)
|
thyroid hormone
(CHEBI:60311)
|
1158: Increased, Hepatic thyroid hormone uptake/transport
|
| 609 |
increased |
catalytic activity
(GO:0003824)
|
beta-1,3-glucuronyltransferase
(PR:000001325)
|
295: Induction, Upregulation of glucuronyltransferase activity
|
| 610 |
increased |
cell maturation
(GO:0048469)
|
gamete
(CL:0000300)
|
1161: Increased, oocyte maturation
|
| 611 |
increased |
reproductive process
(GO:0022414)
|
|
1163: Increased, Reproductive Success
|
| 612 |
increased |
|
population of organisms
(PCO:0000001)
|
1164: Increased, Population
|
| 613 |
premature |
|
spawning
(MESH:C82476)
|
1255: induced spawning
|
| 614 |
increased |
signaling
(GO:0023052)
|
transient receptor potential cation channel TRPV1
(PR:000001065)
|
2 Events
|
| 615 |
increased |
calcium ion transport
(GO:0006816)
|
calcium ion
(CHEBI:39124)
|
2 Events
|
| 616 |
decreased |
rhythmic excitation
(GO:0043179)
|
vagus nerve
(UBERON:0001759)
|
1220: Trigeminal nerve activation
|
| 617 |
increased |
neuropeptide hormone activity
(GO:0005184)
|
Substance P
(CHEBI:80308)
|
1222: SP (Substance P) release, Local increase of SP
|
| 618 |
increased |
reflex
(GO:0060004)
|
trigeminal nerve
(UBERON:0001645)
|
1223: Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea
|
| 619 |
increased |
|
cough
(MESH:D003371)
|
2 Events
|
| 620 |
increased |
|
Respiratory Hypersensitivity
(MESH:D012130)
|
1223: Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea
|
| 621 |
increased |
|
Dyspnea
(MESH:D004417)
|
1223: Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea
|
| 622 |
increased |
dermatitis
(MP:0001194)
|
|
3 Events
|
| 623 |
increased |
cytokine production
(GO:0001816)
|
tumor necrosis factor alpha
(PR:000000134)
|
1224: Non-neuronal production of TNF, Epithelial irritation
|
| 624 |
increased |
abnormal acute inflammation
(MP:0002498)
|
|
1225: Immune system inflammation
|
| 625 |
increased |
inflammatory response
(GO:0006954)
|
respiratory system
(UBERON:0001004)
|
1226: Increased Respiratory irritability and Chronic Cough,
|